drugset / Trial / NCT03451006

Effect of Metformin on Frailty in 12 Subjects

NCT03451006 ↗

Phase 2 Terminated 7 enrolled Mayo Clinic
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will test whether chronic metformin administration will improve longevity of the cell, improves its machinery by reducing aging-related biochemical parameters and thereby improving physical performance, as measured by short physical performance battery test.

Timeline

Start
2018-05-24
Primary completion
2021-12-16
Completion
2021-12-16

Outcome

Outcome not reported

Stopped (Enrollment): “difficult recruitment and not achieved”

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 500 mg Oral

Indications

No indication recorded.